FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2078563039> ?p ?o ?g. }

• W2078563039 abstract "We report a woman who had a moderate elevation of serum triglycerides with a type III pattern of hyperlipoproteinaemia when taking a normal diet. She developed eruptive xanthomata with a grossly raised serum triglyceride concentration and chylomicronaemia when pregnant and also when taking a combined oral contraceptive pill containing 50 microgram of oestrogen. The xanthomata cleared and the triglyceride level fell when the combined oral contraceptive pill was changed to one with a lower oestrogen content, clofibrate was prescribed and the diet was restricted in carbohydrate and fat. Persistent chylomicronaemia is a serious complication of pregnancy because of the risk of pancreatitis and the potential risk of fetal malnutrition. Treatment with diet and clofibrate is indicated. High oestrogen-containing contraceptive pills appear to be contraindicated in patients with type III or other hypertriglyceridaemic states.This case study reports moderate elevation of serum triglycerides in a woman with a Type III pattern of hyperlipoproteinemia, when taking a normal diet but drinking alcohol heavily, who developed eruptive xanthomata with a grossly raised triglyceride concentration and chylomicronemia when pregnant and also when taking a combined oral contraceptive pill (OC) containing 50 mcg of estrogen. In December 1973 the patient, then taking Norinyl 1, was switched to Eugynon 30 (30 mcg of ethinyl estradiol and .25 mg of levonorgestrel), and clofibrate (2 gm/day) was prescribed along with a low carbohydrate and fat content diet. By February 1974 the patient had lost weight, the skin lesions had cleared, serum lipid concentrations had fallen, and the electrophoretic beta-band pattern was normal. The patient became pregnant in October 1974, and by the second trimester of pregnancy xanthomata had recurred, but erratic treatment with clofibrate and diet regulation eventually lowered triglyceride levels and she delivered a 2.61-kg baby at 39 weeks. Persistent chylomicronemia is a serious complication of pregnancy because of the risk of pancreatitis and the potential risk of fetal malnutrition. Similarly, high estrogen-containing OCs are contraindicated in patients with Type III or other hypertriglycidemic states." @default.
• W2078563039 created "2016-06-24" @default.
• W2078563039 creator A5015092104 @default.
• W2078563039 creator A5031489665 @default.
• W2078563039 creator A5070333740 @default.
• W2078563039 creator A5090378481 @default.
• W2078563039 date "1978-02-01" @default.
• W2078563039 modified "2023-09-26" @default.
• W2078563039 title "THE EFFECT OF PREGNANCY AND TWO DIFFERENT CONTRACEPTIVE PILLS ON SERUM LIPIDS AND LIPOPROTEINS IN A WOMAN WITH A TYPE III HYPERLIPOPROTEINAEMIA PATTERN" @default.
• W2078563039 cites W1586612491 @default.
• W2078563039 cites W1808356464 @default.
• W2078563039 cites W1969792135 @default.
• W2078563039 cites W1973624475 @default.
• W2078563039 cites W1988191858 @default.
• W2078563039 cites W1994608135 @default.
• W2078563039 cites W2002812883 @default.
• W2078563039 cites W2008805998 @default.
• W2078563039 cites W2010093960 @default.
• W2078563039 cites W2026847779 @default.
• W2078563039 cites W2027335909 @default.
• W2078563039 cites W2043069344 @default.
• W2078563039 cites W2043301782 @default.
• W2078563039 cites W2070149310 @default.
• W2078563039 cites W2072755464 @default.
• W2078563039 cites W2075742619 @default.
• W2078563039 cites W2077829695 @default.
• W2078563039 cites W2083055771 @default.
• W2078563039 cites W2087755315 @default.
• W2078563039 cites W2090348568 @default.
• W2078563039 cites W2117348699 @default.
• W2078563039 cites W2129389173 @default.
• W2078563039 cites W2129496502 @default.
• W2078563039 cites W2159031152 @default.
• W2078563039 cites W2271049401 @default.
• W2078563039 cites W2397357252 @default.
• W2078563039 cites W4236703259 @default.
• W2078563039 doi "https://doi.org/10.1111/j.1471-0528.1978.tb10466.x" @default.
• W2078563039 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/626721" @default.
• W2078563039 hasPublicationYear "1978" @default.
• W2078563039 type Work @default.
• W2078563039 sameAs 2078563039 @default.
• W2078563039 citedByCount "9" @default.
• W2078563039 countsByYear W20785630392014 @default.
• W2078563039 countsByYear W20785630392022 @default.
• W2078563039 crossrefType "journal-article" @default.
• W2078563039 hasAuthorship W2078563039A5015092104 @default.
• W2078563039 hasAuthorship W2078563039A5031489665 @default.
• W2078563039 hasAuthorship W2078563039A5070333740 @default.
• W2078563039 hasAuthorship W2078563039A5090378481 @default.
• W2078563039 hasConcept C126322002 @default.
• W2078563039 hasConcept C134018914 @default.
• W2078563039 hasConcept C2778163477 @default.
• W2078563039 hasConcept C2778462979 @default.
• W2078563039 hasConcept C2778913445 @default.
• W2078563039 hasConcept C2779076696 @default.
• W2078563039 hasConcept C2779234561 @default.
• W2078563039 hasConcept C2779496863 @default.
• W2078563039 hasConcept C2779496979 @default.
• W2078563039 hasConcept C2780186607 @default.
• W2078563039 hasConcept C2781039349 @default.
• W2078563039 hasConcept C2908647359 @default.
• W2078563039 hasConcept C2986740045 @default.
• W2078563039 hasConcept C2986817661 @default.
• W2078563039 hasConcept C42407357 @default.
• W2078563039 hasConcept C54355233 @default.
• W2078563039 hasConcept C71924100 @default.
• W2078563039 hasConcept C81603835 @default.
• W2078563039 hasConcept C86803240 @default.
• W2078563039 hasConcept C98274493 @default.
• W2078563039 hasConcept C99454951 @default.
• W2078563039 hasConceptScore W2078563039C126322002 @default.
• W2078563039 hasConceptScore W2078563039C134018914 @default.
• W2078563039 hasConceptScore W2078563039C2778163477 @default.
• W2078563039 hasConceptScore W2078563039C2778462979 @default.
• W2078563039 hasConceptScore W2078563039C2778913445 @default.
• W2078563039 hasConceptScore W2078563039C2779076696 @default.
• W2078563039 hasConceptScore W2078563039C2779234561 @default.
• W2078563039 hasConceptScore W2078563039C2779496863 @default.
• W2078563039 hasConceptScore W2078563039C2779496979 @default.
• W2078563039 hasConceptScore W2078563039C2780186607 @default.
• W2078563039 hasConceptScore W2078563039C2781039349 @default.
• W2078563039 hasConceptScore W2078563039C2908647359 @default.
• W2078563039 hasConceptScore W2078563039C2986740045 @default.
• W2078563039 hasConceptScore W2078563039C2986817661 @default.
• W2078563039 hasConceptScore W2078563039C42407357 @default.
• W2078563039 hasConceptScore W2078563039C54355233 @default.
• W2078563039 hasConceptScore W2078563039C71924100 @default.
• W2078563039 hasConceptScore W2078563039C81603835 @default.
• W2078563039 hasConceptScore W2078563039C86803240 @default.
• W2078563039 hasConceptScore W2078563039C98274493 @default.
• W2078563039 hasConceptScore W2078563039C99454951 @default.
• W2078563039 hasLocation W20785630391 @default.
• W2078563039 hasLocation W20785630392 @default.
• W2078563039 hasOpenAccess W2078563039 @default.
• W2078563039 hasPrimaryLocation W20785630391 @default.
• W2078563039 hasRelatedWork W1986341814 @default.
• W2078563039 hasRelatedWork W2018399973 @default.
• W2078563039 hasRelatedWork W2021679290 @default.
• W2078563039 hasRelatedWork W2149955397 @default.
• W2078563039 hasRelatedWork W2715962495 @default.

• next